Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma

Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Robin Park, Fariha Eshrat, Mohammed Al-Jumayli, Azhar Saeed, Anwaar Saeed
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2020-08-01
Serie:Vaccines
Ämnen:
hepatocellular carcinoma
PD-L1
CTLA-4
oncolytic viruses
antigen peptide vaccines
DC vaccines
Länkar:https://www.mdpi.com/2076-393X/8/3/447
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk